SUVEN

SUVEN LIFE SCIENCES

Small Cap BSE: 530239 NSE: SUVEN
₹69.6
-0.05 (-0.07%)
As on 14 August, 2022 | 18:55

Suven Life Sciences Share Price

Suven Life Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Suven Life Sciences Share Returns

  • Over 1 Month 1.31%
  • Over 3 Month -11.03%
  • Over 6 Month -18.74%
  • Over 1 Year -15.45%

Suven Life Sciences Key Statistics

P/E Ratio -10.2
PEG Ratio -5.9
Market Cap Cr 1,012
Price to Book Ratio 10.5
EPS -2.5
Dividend 0
Relative Strength Index 45.27
Money Flow Index 55.95
MACD Signal -0.35
Average True Range 2.46

Suven Life Sciences Investment Rating

  • Master Rating:
  • Suven Life Sciences has an operating revenue of Rs. 13.38 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of -1030% needs improvement, ROE of -126% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Suven Life Sciences Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 4
  • 4
  • 4
  • 1
  • 2
  • 2
  • Operating Expenses Qtr Cr
  • 11
  • 12
  • 11
  • 11
  • 14
  • 10
  • Operating Profit Qtr Cr
  • -7
  • -7
  • -7
  • -10
  • -12
  • -8
  • Depreciation Qtr Cr
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • -2
  • -9
  • -8
  • -11
  • -8
  • -9

Suven Life Sciences Technicals

EMA & SMA

Current Price
69.8
0.15 (0.22%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 70.7
  • 50 Day
  • 72.58
  • 100 Day
  • 76.7
  • 200 Day
  • 84.11
  • 20 Day
  • 70.57
  • 50 Day
  • 71.71
  • 100 Day
  • 78.4
  • 200 Day
  • 84.11

Suven Life Sciences Resistance and Support

PIVOT
₹70.35
Resistance
  • First Resistance
  • 71.16
  • Second Resistance
  • 72.66
  • Third Resistance
  • 73.45
Support
  • First Resistance
  • 68.85
  • Second Resistance
  • 68.05
  • Third Resistance
  • 66.55
  • RSI
  • 45.27
  • MFI
  • 55.95
  • MACD Single Line
  • -0.35
  • MACD
  • -0.32

Suven Life Sciences Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 112,222
  • 5,869,211
  • 52.3
  • Week
  • 189,295
  • 7,013,361
  • 37.05
  • 1 Month
  • 179,360
  • 7,798,569
  • 43.48
  • 6 Month
  • 470,485
  • 16,316,405
  • 34.68

Suven Life Sciences Result Highlights

Suven Life Sciences Synopsis

NSE-Medical-Diversified

Suven Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 11.84 Cr. and Equity Capital is Rs. 14.54 Cr. for the Year ended 31/03/2022. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.
  • Market Cap
  • 1,015
  • Sales
  • 13
  • Shares in Float
  • 5.09
  • No of funds
  • 18
  • Yield
  • 0.89
  • Book Value
  • 2.13
  • U/D Vol ratio
  • 2.1
  • LTDebt / Equity
  • Alpha
  • -0.05
  • Beta
  • 1.33

Suven Life Sciences

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 64.98%
  • 64.98%
  • 60%
  • Mutual Funds
  • 0.01%
  • 0.01%
  • 0.01%
  • Foreign Portfolio Investors
  • 0.45%
  • 0.45%
  • 0.52%
  • Financial Institutions/ Banks
  • Individual Investors
  • 29.02%
  • 28.7%
  • 33.25%
  • Others
  • 5.54%
  • 5.86%
  • 6.22%

Suven Life Sciences Management

  • Name
  • Designation
  • Mr. Venkateswarlu Jasti
  • Chairman & CEO
  • Mrs. Sudharani Jasti
  • Whole Time Director
  • Mrs. J A S Padmaja
  • Director
  • Prof. Seyed E Hasnain
  • Director
  • Mr. M Gopalakrishna
  • Director
  • Mr. Santanu Mukherjee
  • Director

Suven Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Suven Life Sciences Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-26
  • Quarterly Results
  • 2022-06-24
  • Rights issue
  • Inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company. per share(150%)Interim Dividend
  • 2022-05-07
  • Audited Results
  • 2022-01-31
  • Quarterly Results
  • 2021-10-25
  • Quarterly Results

Suven Life Sciences MF Shareholding

  • Name
  • Amount(cr)
  • Motilal Oswal S&P BSE Healthcare ETF

Suven Life Sciences FAQs

What is Share Price of Suven Life Sciences ?

Suven Life Sciences share price is ₹69 As on 14 August, 2022 | 18:41

What is the Market Cap of Suven Life Sciences ?

The Market Cap of Suven Life Sciences is ₹1011.9 Cr As on 14 August, 2022 | 18:41

What is the P/E ratio of Suven Life Sciences ?

The P/E ratio of Suven Life Sciences is -10.2 As on 14 August, 2022 | 18:41

What is the PB ratio of Suven Life Sciences ?

The PB ratio of Suven Life Sciences is 10.5 As on 14 August, 2022 | 18:41

Q1FY23